Index by author

February 01, 2001; Volume 28,Issue 2

A

  1. Adachi, J

    1. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;

  2. Aho, K

    1. Uveitis as a cause of visual loss in arthritides and comparable conditions.
      K Kotaniemi, K Aho and A Kotaniemi
      The Journal of Rheumatology February 1 2001, 28 (2) 309-312;

  3. Anderson, J

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  4. Anderson, J J

    1. A review of evidence on the discriminant validity of outcome measures in rheumatoid arthritis.
      D T Felson and J J Anderson
      The Journal of Rheumatology February 1 2001, 28 (2) 422-426;

  5. Angleés-Cano, E

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

  6. Arai, Y

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  7. Aranow, C

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

B

  1. Baeten, D

    1. Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.
      F van den Bosch, D Baeten, E Kruithof, F de Keyser and E M Veys
      The Journal of Rheumatology February 1 2001, 28 (2) 392-393;

  2. Bardak, Y

    1. Epidemiologic and clinical features of Behçet's disease.
      Y Bardak
      The Journal of Rheumatology February 1 2001, 28 (2) 455-456;

  3. Barrett, J H

    1. Women with inflammatory polyarthritis have babies of lower birth weight.
      A P Bowden, J H Barrett, W Fallow and A J Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 355-359;

  4. Beaton, D

    1. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    2. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  5. Beaton, D E

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;
    2. Minimal clinically important difference. Low back pain: outcome measures.
      C Bombardier, J Hayden and D E Beaton
      The Journal of Rheumatology February 1 2001, 28 (2) 431-438;

  6. Bellamy, N

    1. Towards a definition of "difference" in osteoarthritis.
      N Bellamy, A Carr, M Dougados, B Shea and G Wells
      The Journal of Rheumatology February 1 2001, 28 (2) 427-430;
    2. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  7. Berner, C M

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  8. Bloch, K J

    1. Hypocomplementemic urticarial vasculitis, jaccoud's arthropathy, valvular heart disease, and reversible tracheal stenosis: a surfeit of syndromes.
      H J Chen and K J Bloch
      The Journal of Rheumatology February 1 2001, 28 (2) 383-386;

  9. Boers, M

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;
    2. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    3. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  10. Bombardier, C

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;
    2. Minimal clinically important difference. Low back pain: outcome measures.
      C Bombardier, J Hayden and D E Beaton
      The Journal of Rheumatology February 1 2001, 28 (2) 431-438;
    3. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  11. Bornmyr, S V

    1. Sympathetic dysfunction in patients with primary Sjögren's syndrome.
      T Mandl, S V Bornmyr, J Castenfors, L T Jacobsson, R Manthorpe and P Wollmer
      The Journal of Rheumatology February 1 2001, 28 (2) 296-301;

  12. Bourgeois, P

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  13. Bowden, A P

    1. Women with inflammatory polyarthritis have babies of lower birth weight.
      A P Bowden, J H Barrett, W Fallow and A J Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 355-359;

  14. Breedveld, F

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  15. Brooks, P

    1. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;

  16. Brucato, A

    1. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
      E Theander, A Brucato, S Gudmundsson, S Salomonsson, M Wahren-Herlenius and R Manthorpe
      The Journal of Rheumatology February 1 2001, 28 (2) 373-376;

C

  1. Cacoub, P

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

  2. Carr, A

    1. Towards a definition of "difference" in osteoarthritis.
      N Bellamy, A Carr, M Dougados, B Shea and G Wells
      The Journal of Rheumatology February 1 2001, 28 (2) 427-430;
    2. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  3. Cash, J M

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  4. Castenfors, J

    1. Sympathetic dysfunction in patients with primary Sjögren's syndrome.
      T Mandl, S V Bornmyr, J Castenfors, L T Jacobsson, R Manthorpe and P Wollmer
      The Journal of Rheumatology February 1 2001, 28 (2) 296-301;

  5. Chen, H J

    1. Hypocomplementemic urticarial vasculitis, jaccoud's arthropathy, valvular heart disease, and reversible tracheal stenosis: a surfeit of syndromes.
      H J Chen and K J Bloch
      The Journal of Rheumatology February 1 2001, 28 (2) 383-386;

  6. Ciancio, G

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  7. Clinch, J

    1. Individualized functional priority approach to the assessment of health related quality of life in rheumatology.
      J Clinch, P Tugwell, G Wells and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 445-451;

  8. Coutts, S

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  9. Cranney, A

    1. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;
    2. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  10. Cronin, M E

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

D

  1. Dawes, P T

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  2. de Haan, H A

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  3. de Keyser, F

    1. Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.
      F van den Bosch, D Baeten, E Kruithof, F de Keyser and E M Veys
      The Journal of Rheumatology February 1 2001, 28 (2) 392-393;

  4. Dequeker, J

    1. Globalization of rheumatology: activities of ILAR. Think global--act local. International League of Associations for Rheumatology.
      J Dequeker, J J Rasker and T El-Hadidi
      The Journal of Rheumatology February 1 2001, 28 (2) 227-231;

  5. Dominguez, M

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

  6. Dougados, M

    1. Towards a definition of "difference" in osteoarthritis.
      N Bellamy, A Carr, M Dougados, B Shea and G Wells
      The Journal of Rheumatology February 1 2001, 28 (2) 427-430;
    2. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  7. Duprez, T

    1. Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms.
      T Duprez, A Nzeusseu, A Peeters and F A Houssiau
      The Journal of Rheumatology February 1 2001, 28 (2) 387-391;

E

  1. El-Hadidi, T

    1. Globalization of rheumatology: activities of ILAR. Think global--act local. International League of Associations for Rheumatology.
      J Dequeker, J J Rasker and T El-Hadidi
      The Journal of Rheumatology February 1 2001, 28 (2) 227-231;

  2. Emery, P

    1. Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?
      H Marzo-Ortega, S Misbah and P Emery
      The Journal of Rheumatology February 1 2001, 28 (2) 377-378;

F

  1. Fallow, W

    1. Women with inflammatory polyarthritis have babies of lower birth weight.
      A P Bowden, J H Barrett, W Fallow and A J Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 355-359;

  2. Fantini, F

    1. Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria.
      F Fantini
      The Journal of Rheumatology February 1 2001, 28 (2) 456-459;

  3. Fautrel, B

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  4. Felson, D

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  5. Felson, D T

    1. A review of evidence on the discriminant validity of outcome measures in rheumatoid arthritis.
      D T Felson and J J Anderson
      The Journal of Rheumatology February 1 2001, 28 (2) 422-426;

  6. Finn, J

    1. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
      A Herrick, B Rooney, J Finn and A Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 292-295;

  7. Furie, R A

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

G

  1. Garcia-Porrua, C

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  2. Garcia de la Torre, I

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

  3. Gilboe, I M

    1. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
      I M Gilboe, T K Kvien and G Husby
      The Journal of Rheumatology February 1 2001, 28 (2) 266-274;

  4. Godeau, P

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

  5. Goldsmith, C H

    1. Low back pain: prevalence and risk factors in an industrial setting.
      P Lee, A Helewa, C H Goldsmith, H A Smythe and L W Stitt
      The Journal of Rheumatology February 1 2001, 28 (2) 346-351;

  6. Gonzalez-Gay, M A

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  7. Gordon, P A

    1. Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.
      P A Gordon, E Rosenthal, M A Khamashta and G R Hughes
      The Journal of Rheumatology February 1 2001, 28 (2) 366-369;

  8. Gudmundsson, S

    1. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
      E Theander, A Brucato, S Gudmundsson, S Salomonsson, M Wahren-Herlenius and R Manthorpe
      The Journal of Rheumatology February 1 2001, 28 (2) 373-376;

  9. Guillevin, L

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

H

  1. Hajeer, A H

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  2. Hamuro, J

    1. Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints.
      J Nishio, H Kohsaka, T Shimamura, J Hamuro and N Miyasaka
      The Journal of Rheumatology February 1 2001, 28 (2) 240-244;

  3. Hasegawa, Y

    1. Concentration and localization of YKL-40 in hip joint diseases.
      M Kawasaki, Y Hasegawa, S Kondo and H Iwata
      The Journal of Rheumatology February 1 2001, 28 (2) 341-345;

  4. Hayashi, Y

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  5. Hayden, J

    1. Minimal clinically important difference. Low back pain: outcome measures.
      C Bombardier, J Hayden and D E Beaton
      The Journal of Rheumatology February 1 2001, 28 (2) 431-438;

  6. Helewa, A

    1. Low back pain: prevalence and risk factors in an industrial setting.
      P Lee, A Helewa, C H Goldsmith, H A Smythe and L W Stitt
      The Journal of Rheumatology February 1 2001, 28 (2) 346-351;

  7. Herrick, A

    1. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
      A Herrick, B Rooney, J Finn and A Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 292-295;

  8. Higginbotham, E A

    1. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
      E A Higginbotham, S A Zimmerman, T A Howard, L Schanberg, D Kredich and R E Ware
      The Journal of Rheumatology February 1 2001, 28 (2) 370-372;

  9. Hirasawa, Y

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  10. Houssiau, F A

    1. Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms.
      T Duprez, A Nzeusseu, A Peeters and F A Houssiau
      The Journal of Rheumatology February 1 2001, 28 (2) 387-391;

  11. Howard, T A

    1. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
      E A Higginbotham, S A Zimmerman, T A Howard, L Schanberg, D Kredich and R E Ware
      The Journal of Rheumatology February 1 2001, 28 (2) 370-372;

  12. Huang, C H

    1. Corneal melt as the initial presentation of primary Sjögren's syndrome.
      F B Vivino, P Minerva, C H Huang and S E Orlin
      The Journal of Rheumatology February 1 2001, 28 (2) 379-382;

  13. Hudson, N P

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  14. Hughes, G R

    1. Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.
      P A Gordon, E Rosenthal, M A Khamashta and G R Hughes
      The Journal of Rheumatology February 1 2001, 28 (2) 366-369;

  15. Huizinga, T W

    1. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
      M W van der Linden, R G Westendorp, M Zidane, L Meheus and T W Huizinga
      The Journal of Rheumatology February 1 2001, 28 (2) 284-287;

  16. Husby, G

    1. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
      I M Gilboe, T K Kvien and G Husby
      The Journal of Rheumatology February 1 2001, 28 (2) 266-274;

I

  1. Ichikawa, Y

    1. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
      R Uehara, Y Suzuki and Y Ichikawa
      The Journal of Rheumatology February 1 2001, 28 (2) 251-256;

  2. Ikeda, T

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  3. Imanishi, J

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  4. Iwamoto, I

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  5. Iwata, H

    1. Concentration and localization of YKL-40 in hip joint diseases.
      M Kawasaki, Y Hasegawa, S Kondo and H Iwata
      The Journal of Rheumatology February 1 2001, 28 (2) 341-345;

J

  1. Jacobsson, L T

    1. Sympathetic dysfunction in patients with primary Sjögren's syndrome.
      T Mandl, S V Bornmyr, J Castenfors, L T Jacobsson, R Manthorpe and P Wollmer
      The Journal of Rheumatology February 1 2001, 28 (2) 296-301;

K

  1. Katayama, Y

    1. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
      Y Katayama and K Kohriyama
      The Journal of Rheumatology February 1 2001, 28 (2) 288-291;

  2. Katz, J N

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;

  3. Katz, R S

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  4. Kawamura, N

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  5. Kawasaki, M

    1. Concentration and localization of YKL-40 in hip joint diseases.
      M Kawasaki, Y Hasegawa, S Kondo and H Iwata
      The Journal of Rheumatology February 1 2001, 28 (2) 341-345;

  6. Khamashta, M A

    1. Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.
      P A Gordon, E Rosenthal, M A Khamashta and G R Hughes
      The Journal of Rheumatology February 1 2001, 28 (2) 366-369;

  7. Kietz, D A

    1. Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis.
      D A Kietz, P H Pepmueller and T L Moore
      The Journal of Rheumatology February 1 2001, 28 (2) 360-362;

  8. Kirwan, J

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  9. Kirwan, J R

    1. Minimum clinically important difference: the crock of gold at the end of the rainbow?
      J R Kirwan
      The Journal of Rheumatology February 1 2001, 28 (2) 439-444;

  10. Kita, Y

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  11. Kitajima, I

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  12. Kobayashi, I

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  13. Kobayashi, K

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  14. Koeger, A C

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  15. Kohriyama, K

    1. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
      Y Katayama and K Kohriyama
      The Journal of Rheumatology February 1 2001, 28 (2) 288-291;

  16. Kohsaka, H

    1. Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints.
      J Nishio, H Kohsaka, T Shimamura, J Hamuro and N Miyasaka
      The Journal of Rheumatology February 1 2001, 28 (2) 240-244;

  17. Kondo, S

    1. Concentration and localization of YKL-40 in hip joint diseases.
      M Kawasaki, Y Hasegawa, S Kondo and H Iwata
      The Journal of Rheumatology February 1 2001, 28 (2) 341-345;

  18. Kotaniemi, A

    1. Uveitis as a cause of visual loss in arthritides and comparable conditions.
      K Kotaniemi, K Aho and A Kotaniemi
      The Journal of Rheumatology February 1 2001, 28 (2) 309-312;

  19. Kotaniemi, K

    1. Uveitis as a cause of visual loss in arthritides and comparable conditions.
      K Kotaniemi, K Aho and A Kotaniemi
      The Journal of Rheumatology February 1 2001, 28 (2) 309-312;

  20. Kredich, D

    1. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
      E A Higginbotham, S A Zimmerman, T A Howard, L Schanberg, D Kredich and R E Ware
      The Journal of Rheumatology February 1 2001, 28 (2) 370-372;

  21. Kruithof, E

    1. Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.
      F van den Bosch, D Baeten, E Kruithof, F de Keyser and E M Veys
      The Journal of Rheumatology February 1 2001, 28 (2) 392-393;

  22. Kubo, T

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  23. Kurasawa, K

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  24. Kuzis, S

    1. Risk factors for work disability in patients with ankylosing spondylitis.
      M M Ward and S Kuzis
      The Journal of Rheumatology February 1 2001, 28 (2) 315-321;

  25. Kvien, T K

    1. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
      I M Gilboe, T K Kvien and G Husby
      The Journal of Rheumatology February 1 2001, 28 (2) 266-274;

L

  1. La Civita, L

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  2. Lee, P

    1. Low back pain: prevalence and risk factors in an industrial setting.
      P Lee, A Helewa, C H Goldsmith, H A Smythe and L W Stitt
      The Journal of Rheumatology February 1 2001, 28 (2) 346-351;

  3. Le Moël, G

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  4. Liebling, M R

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  5. Livingston, M C

    1. Whiplash injury and hippocrates: practical points for contemporary practitioners.
      M C Livingston
      The Journal of Rheumatology February 1 2001, 28 (2) 352-354;

M

  1. Mandl, T

    1. Sympathetic dysfunction in patients with primary Sjögren's syndrome.
      T Mandl, S V Bornmyr, J Castenfors, L T Jacobsson, R Manthorpe and P Wollmer
      The Journal of Rheumatology February 1 2001, 28 (2) 296-301;

  2. Manthorpe, R

    1. Sympathetic dysfunction in patients with primary Sjögren's syndrome.
      T Mandl, S V Bornmyr, J Castenfors, L T Jacobsson, R Manthorpe and P Wollmer
      The Journal of Rheumatology February 1 2001, 28 (2) 296-301;
    2. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
      E Theander, A Brucato, S Gudmundsson, S Salomonsson, M Wahren-Herlenius and R Manthorpe
      The Journal of Rheumatology February 1 2001, 28 (2) 373-376;

  3. Marzo-Ortega, H

    1. Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?
      H Marzo-Ortega, S Misbah and P Emery
      The Journal of Rheumatology February 1 2001, 28 (2) 377-378;

  4. Mattey, D L

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  5. Mazda, O

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  6. Meheus, L

    1. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
      M W van der Linden, R G Westendorp, M Zidane, L Meheus and T W Huizinga
      The Journal of Rheumatology February 1 2001, 28 (2) 284-287;

  7. Merskey, H

    1. Whiplash and the clinician.
      H Merskey
      The Journal of Rheumatology February 1 2001, 28 (2) 223-224;

  8. Meyer, O

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  9. Minerva, P

    1. Corneal melt as the initial presentation of primary Sjögren's syndrome.
      F B Vivino, P Minerva, C H Huang and S E Orlin
      The Journal of Rheumatology February 1 2001, 28 (2) 379-382;

  10. Misbah, S

    1. Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?
      H Marzo-Ortega, S Misbah and P Emery
      The Journal of Rheumatology February 1 2001, 28 (2) 377-378;

  11. Miyasaka, N

    1. Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints.
      J Nishio, H Kohsaka, T Shimamura, J Hamuro and N Miyasaka
      The Journal of Rheumatology February 1 2001, 28 (2) 240-244;

  12. Mizumoto, M

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  13. Moore, T L

    1. Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis.
      D A Kietz, P H Pepmueller and T L Moore
      The Journal of Rheumatology February 1 2001, 28 (2) 360-362;

N

  1. Nawata, Y

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  2. Nishio, J

    1. Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints.
      J Nishio, H Kohsaka, T Shimamura, J Hamuro and N Miyasaka
      The Journal of Rheumatology February 1 2001, 28 (2) 240-244;

  3. Nzeusseu, A

    1. Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms.
      T Duprez, A Nzeusseu, A Peeters and F A Houssiau
      The Journal of Rheumatology February 1 2001, 28 (2) 387-391;

O

  1. Ohashi, S

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  2. Oishi, Y

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  3. Okano, M

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  4. Olivieri, I

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  5. Ollier, W E

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  6. Orlin, S E

    1. Corneal melt as the initial presentation of primary Sjögren's syndrome.
      F B Vivino, P Minerva, C H Huang and S E Orlin
      The Journal of Rheumatology February 1 2001, 28 (2) 379-382;

P

  1. Padula, A

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  2. Peeters, A

    1. Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms.
      T Duprez, A Nzeusseu, A Peeters and F A Houssiau
      The Journal of Rheumatology February 1 2001, 28 (2) 387-391;

  3. Pepmueller, P H

    1. Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis.
      D A Kietz, P H Pepmueller and T L Moore
      The Journal of Rheumatology February 1 2001, 28 (2) 360-362;

  4. Piccirillo, A

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  5. Piette, J C

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  6. Piette, T J

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

R

  1. Rasker, J J

    1. Globalization of rheumatology: activities of ILAR. Think global--act local. International League of Associations for Rheumatology.
      J Dequeker, J J Rasker and T El-Hadidi
      The Journal of Rheumatology February 1 2001, 28 (2) 227-231;

  2. Reilly, P A

    1. Occupational low back pain.
      P A Reilly
      The Journal of Rheumatology February 1 2001, 28 (2) 225-226;

  3. Ricciuti, F

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  4. Rooney, B

    1. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
      A Herrick, B Rooney, J Finn and A Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 292-295;

  5. Rosenthal, E

    1. Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.
      P A Gordon, E Rosenthal, M A Khamashta and G R Hughes
      The Journal of Rheumatology February 1 2001, 28 (2) 366-369;

  6. Rothschild, B M

    1. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus.
      B M Rothschild
      The Journal of Rheumatology February 1 2001, 28 (2) 455;
    2. Rheumatoid arthritis at a time of passage.
      B M Rothschild
      The Journal of Rheumatology February 1 2001, 28 (2) 245-250;

  7. Rozenberg, S

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

S

  1. Sadowski, T

    1. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes.
      T Sadowski and J Steinmeyer
      The Journal of Rheumatology February 1 2001, 28 (2) 336-340;

  2. Saint-Marcoux, B

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  3. Saito, Y

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  4. Sakamoto, A

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  5. Salazar-Paramo, M

    1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
      M Dominguez, P Cacoub, I Garcia de la Torre, T J Piette, M Salazar-Paramo, P Godeau and E Angleés-Cano
      The Journal of Rheumatology February 1 2001, 28 (2) 302-308;

  6. Salomonsson, S

    1. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
      E Theander, A Brucato, S Gudmundsson, S Salomonsson, M Wahren-Herlenius and R Manthorpe
      The Journal of Rheumatology February 1 2001, 28 (2) 373-376;

  7. Scarano, E

    1. Association between vitiligo and spondyloarthritis.
      A Padula, G Ciancio, L La Civita, E Scarano, F Ricciuti, A Piccirillo and I Olivieri
      The Journal of Rheumatology February 1 2001, 28 (2) 313-314;

  8. Schanberg, L

    1. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
      E A Higginbotham, S A Zimmerman, T A Howard, L Schanberg, D Kredich and R E Ware
      The Journal of Rheumatology February 1 2001, 28 (2) 370-372;

  9. Schiff, M

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  10. Shea, B

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;
    2. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    3. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;
    4. Towards a definition of "difference" in osteoarthritis.
      N Bellamy, A Carr, M Dougados, B Shea and G Wells
      The Journal of Rheumatology February 1 2001, 28 (2) 427-430;
    5. Individualized functional priority approach to the assessment of health related quality of life in rheumatology.
      J Clinch, P Tugwell, G Wells and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 445-451;
    6. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  11. Shikano, T

    1. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
      I Kobayashi, N Kawamura, M Okano, T Shikano, M Mizumoto, Y Hayashi and K Kobayashi
      The Journal of Rheumatology February 1 2001, 28 (2) 363-365;

  12. Shimamura, T

    1. Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints.
      J Nishio, H Kohsaka, T Shimamura, J Hamuro and N Miyasaka
      The Journal of Rheumatology February 1 2001, 28 (2) 240-244;

  13. Silman, A

    1. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
      A Herrick, B Rooney, J Finn and A Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 292-295;

  14. Silman, A J

    1. Women with inflammatory polyarthritis have babies of lower birth weight.
      A P Bowden, J H Barrett, W Fallow and A J Silman
      The Journal of Rheumatology February 1 2001, 28 (2) 355-359;

  15. Simon, L

    1. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    2. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;
    3. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  16. Smolen, J

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  17. Smythe, H A

    1. Low back pain: prevalence and risk factors in an industrial setting.
      P Lee, A Helewa, C H Goldsmith, H A Smythe and L W Stitt
      The Journal of Rheumatology February 1 2001, 28 (2) 346-351;

  18. Steinmeyer, J

    1. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes.
      T Sadowski and J Steinmeyer
      The Journal of Rheumatology February 1 2001, 28 (2) 336-340;

  19. Stitt, L W

    1. Low back pain: prevalence and risk factors in an industrial setting.
      P Lee, A Helewa, C H Goldsmith, H A Smythe and L W Stitt
      The Journal of Rheumatology February 1 2001, 28 (2) 346-351;

  20. Strand, V

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;
    2. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    3. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  21. Sumida, T

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  22. Suzuki, Y

    1. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
      R Uehara, Y Suzuki and Y Ichikawa
      The Journal of Rheumatology February 1 2001, 28 (2) 251-256;

T

  1. Takabayashi, K

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  2. Takahashi, H

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  3. Takahashi, K

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  4. Takigawa, M

    1. Expression of transduced HSP70 gene protects chondrocytes from stress.
      T Kubo, Y Arai, K Takahashi, T Ikeda, S Ohashi, I Kitajima, O Mazda, M Takigawa, J Imanishi and Y Hirasawa
      The Journal of Rheumatology February 1 2001, 28 (2) 330-335;

  5. Taniguchi, M

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

  6. Taupin, P

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  7. Theander, E

    1. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
      E Theander, A Brucato, S Gudmundsson, S Salomonsson, M Wahren-Herlenius and R Manthorpe
      The Journal of Rheumatology February 1 2001, 28 (2) 373-376;

  8. Thomson, W

    1. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
      D L Mattey, P T Dawes, M A Gonzalez-Gay, C Garcia-Porrua, W Thomson, A H Hajeer and W E Ollier
      The Journal of Rheumatology February 1 2001, 28 (2) 232-239;

  9. Tugwell, P

    1. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    2. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;
    3. Individualized functional priority approach to the assessment of health related quality of life in rheumatology.
      J Clinch, P Tugwell, G Wells and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 445-451;
    4. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

U

  1. Uehara, R

    1. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
      R Uehara, Y Suzuki and Y Ichikawa
      The Journal of Rheumatology February 1 2001, 28 (2) 251-256;

V

  1. van den Bosch, F

    1. Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.
      F van den Bosch, D Baeten, E Kruithof, F de Keyser and E M Veys
      The Journal of Rheumatology February 1 2001, 28 (2) 392-393;

  2. van der Linden, M W

    1. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
      M W van der Linden, R G Westendorp, M Zidane, L Meheus and T W Huizinga
      The Journal of Rheumatology February 1 2001, 28 (2) 284-287;

  3. van Riel, P

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  4. Veys, E M

    1. Characteristic marco- and microscopic aspect of the synovial membrane in crystal induced arthritis.
      F van den Bosch, D Baeten, E Kruithof, F de Keyser and E M Veys
      The Journal of Rheumatology February 1 2001, 28 (2) 392-393;

  5. Vignes, S

    1. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease.
      B Fautrel, G Le Moël, B Saint-Marcoux, P Taupin, S Vignes, S Rozenberg, A C Koeger, O Meyer, L Guillevin, J C Piette and P Bourgeois
      The Journal of Rheumatology February 1 2001, 28 (2) 322-329;

  6. Vivino, F B

    1. Corneal melt as the initial presentation of primary Sjögren's syndrome.
      F B Vivino, P Minerva, C H Huang and S E Orlin
      The Journal of Rheumatology February 1 2001, 28 (2) 379-382;

W

  1. Wahren-Herlenius, M

    1. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
      E Theander, A Brucato, S Gudmundsson, S Salomonsson, M Wahren-Herlenius and R Manthorpe
      The Journal of Rheumatology February 1 2001, 28 (2) 373-376;

  2. Ward, M M

    1. Risk factors for work disability in patients with ankylosing spondylitis.
      M M Ward and S Kuzis
      The Journal of Rheumatology February 1 2001, 28 (2) 315-321;

  3. Ware, R E

    1. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
      E A Higginbotham, S A Zimmerman, T A Howard, L Schanberg, D Kredich and R E Ware
      The Journal of Rheumatology February 1 2001, 28 (2) 370-372;

  4. Weisman, M H

    1. Treatment of systemic lupus erythematosus with LJP 394.
      R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, M R Liebling, N P Hudson, C M Berner, S Coutts and H A de Haan
      The Journal of Rheumatology February 1 2001, 28 (2) 257-265;

  5. Welch, V

    1. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;

  6. Welch, V A

    1. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  7. Wells, G

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;
    2. Minimal clinically important differences: review of methods.
      G Wells, D Beaton, B Shea, M Boers, L Simon, V Strand, P Brooks and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 406-412;
    3. Discrimination of changes in osteoporosis outcomes.
      A Cranney, V Welch, G Wells, J Adachi, B Shea, L Simon and P Tugwell
      The Journal of Rheumatology February 1 2001, 28 (2) 413-421;
    4. Towards a definition of "difference" in osteoarthritis.
      N Bellamy, A Carr, M Dougados, B Shea and G Wells
      The Journal of Rheumatology February 1 2001, 28 (2) 427-430;
    5. Individualized functional priority approach to the assessment of health related quality of life in rheumatology.
      J Clinch, P Tugwell, G Wells and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 445-451;
    6. Minimal clinically important difference module: summary, recommendations, and research agenda.
      G Wells, J Anderson, D Beaton, N Bellamy, M Boers, C Bombardier, F Breedveld, A Carr, A Cranney, M Dougados, D Felson, J Kirwan, M Schiff, B Shea, L Simon, J Smolen, V Strand, P Tugwell, P van Riel and V A Welch
      The Journal of Rheumatology February 1 2001, 28 (2) 452-454;

  8. Westendorp, R G

    1. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
      M W van der Linden, R G Westendorp, M Zidane, L Meheus and T W Huizinga
      The Journal of Rheumatology February 1 2001, 28 (2) 284-287;

  9. Wollmer, P

    1. Sympathetic dysfunction in patients with primary Sjögren's syndrome.
      T Mandl, S V Bornmyr, J Castenfors, L T Jacobsson, R Manthorpe and P Wollmer
      The Journal of Rheumatology February 1 2001, 28 (2) 296-301;

  10. Wright, J G

    1. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.
      D E Beaton, C Bombardier, J N Katz, J G Wright, G Wells, M Boers, V Strand and B Shea
      The Journal of Rheumatology February 1 2001, 28 (2) 400-405;

Y

  1. Yoshida, S

    1. Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.
      Y Oishi, T Sumida, A Sakamoto, Y Kita, K Kurasawa, Y Nawata, K Takabayashi, H Takahashi, S Yoshida, M Taniguchi, Y Saito and I Iwamoto
      The Journal of Rheumatology February 1 2001, 28 (2) 275-283;

Z

  1. Zidane, M

    1. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
      M W van der Linden, R G Westendorp, M Zidane, L Meheus and T W Huizinga
      The Journal of Rheumatology February 1 2001, 28 (2) 284-287;

  2. Zimmerman, S A

    1. Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus.
      E A Higginbotham, S A Zimmerman, T A Howard, L Schanberg, D Kredich and R E Ware
      The Journal of Rheumatology February 1 2001, 28 (2) 370-372;
Back to top

In this issue